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Abstract
Objectives—To determine the Minimal Clinically Important Difference (MCID) and Robust 
Clinically Important Difference (RCID) of the Mayo-Portland Adaptability Inventory (MPAI-4) as 
measures of response to intervention.
Methods—Retrospective analysis of existing data. Both distribution- and anchor-based methods 
were used to triangulate on the MCID and to identify a moderate, i.e., more robust, level of change 
(RCID) for the MPAI-4. These were further evaluated with respect to clinical provider ratings.
Participants—Data for individuals with acquired brain injury in rehabilitation programs 
throughout the U.S. in the OutcomeInfo Database (n=3087) with two MPAI-4 ratings.
Main Measures—MPAI-4, Supervision Rating Scale (SRS), Clinician Rating of Global Clinical 
Improvement (CRGCI).
Results—Initial analyses suggested 5 T-score points (5T) as the MCID and 9T as the RCID. 81–
87% of clinical raters considered a 5T change and 99% considered a 9T change to indicate 
meaningful improvement.
Conclusions—5T represents the MCID for the MPAI-4 and 9T, the RCID. Both values are 
notably less than the Reliable Change Index (RCI). While the RCI indicates change with a high 
level of statistical confidence, it may be insensitive to change that is considered meaningful by 
providers and participants as indicated by the MCID.
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An increasing emphasis on individualized medicine has turned the focus from studies 
documenting mean differences between treatment and control conditions toward trials that 
not only demonstrate treatment efficacy but also identify the characteristics of those who 
benefit from the treatment (responders). We have shown in previous studies1,2 that the 
precision of frequently-used traumatic brain injury (TBI) outcome measures can be 
improved through Rasch analysis resulting in an interval equivalent measurement metric. We 
have applied Rasch analysis to MPAI-4 data and demonstrated the responsiveness of 
MPAI-4 metrics to acquired brain injury (ABI) rehabilitation treatment.3–5 Identification of 
the Minimal Clinically Important Difference (MCID) for MPAI-4 is an essential next step to 
clearly identifying responders to a given intervention evaluated with this measure. 
Systematic reviews of comprehensive rehabilitation interventions have indicated that studies 
to date have been minimally informative, in part due to the lack of identification of MCID 
for outcome measures.6 In order to provide the field with a critical metric to assess efficacy 
and identify responders across a range of outcomes in future rehabilitation treatment 
research, this study was designed to identify the MCID for the MPAI-4.
The MCID, as the name implies, represents the smallest change on a measure that is reliably 
associated with a meaningful change in the patient’s clinical status, function, or quality of 
life. Using the MCID, efficacy of a new treatment can be assessed by the proportion of 
individuals who receive benefit (rather than by group means), providing a concrete and 
pragmatic answer to the question posed by most practicing clinicians: what is the probability 
that the patient in front of me will benefit from this treatment?
There is no universally accepted way to establish MCID, and many ways have been 
proposed.7–10 One set of approaches to determine the MCID uses distribution-based 
analyses and calculates the standard error of measurement (SEM). Another set seeks to 
determine the MCID with reference to external anchors, that is, other indicators of clinical 
change. Current literature on MCID methodology recommends using both distribution-based 
and anchored methods to triangulate on the best value for the MCID for a given measure.9 In 
this study, we aimed to establish the MCID using such a multi-modal method with Rasch-
calibrated MPAI-4 data. In addition, we sought to identify a change that indicated a 
moderate effect which we refer to as the Robust Clinically Important Difference (RCID).
Method
Participants
Data used in this study were obtained from individuals who had been rated on the MPAI-4 
on two occasions with data recorded in the national OutcomeInfo Database. Participants 
were 3087 individuals (65% male) with a mean age of 46.56 years (SD = 14.41 yrs) who 
were an average of 586.78 days (SD = 1788.59 days) post-injury at the time of program 
admission. These individuals were injured at an average age of 44.19 yrs (SD = 15.57 yrs). 
All cases submitted to the database were identified by contributing providers as having a 
history of ABI (e.g., open or closed traumatic brain injury, stroke, infection, tumor, anoxia). 
However, detailed diagnostic information was not available on most cases. Our previous 
analyses comparing MPAI-4 responses between two major diagnostic categories (TBI vs. 
stroke) in post-inpatient brain injury rehabilitation samples revealed differential item 
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functioning for some items; however, examination of differential test functioning showed 
very similar metrics between the two groups at the test level, i.e., test characteristic curves 
were virtually identical.4 This finding supports combining diagnostic groups in this and 
other types of analyses in which the focus is on evaluating measures of function rather than 
measures of diagnostic signs and symptoms.
These individuals participated in 1 of 3 types of programs: Intensive Residential 
Rehabilitation (n=205), Intensive Community-based/Outpatient Rehabilitation (n=2781), 
and Residential or Community-based Supported Living (n=101). MPAI-4 profiles were 
obtained on admission and discharge from intensive rehabilitation programs and on 
admission and at the first subsequent follow-up for those receiving supported living services. 
Analysis of MPAI-4 outcomes showed significant improvement for those receiving intensive 
rehabilitation and stable functioning for those in supported living from first to second 
assessments. More detailed program descriptions and complete results of these analyses are 
available in a prior report.5 Anchored estimations of the MCID were also conducted with 
reference to the Supervision Rating Scale (SRS) using a subsample with available SRS data 
(n = 2726).
OutcomeInfo Database
OutcomeInfo11, a web-based database system developed through a NIH Small Business 
Technology Transfer (STTR) grant, was designed to facilitate monitoring of progress and 
outcomes in post-inpatient programs primarily with the Mayo-Portland Adaptability 
Inventory (MPAI-4) as well as additional measures specific to each provider. Demographic 
and injury-related information about participants are also collected. Participating provider 
organizations do so on a volunteer basis and pay a subscription fee for data management and 
reporting. Data are managed at a HIPAA-approved level of security. Each contributing 
organization has complete access to their own data. However, analyses, such as the one 
reported here that combine data across organizations are conducted with anonymity of both 
cases and organizations. The data used here represents participants in 23 facilities operated 
by 9 different organizations in 14 states in the northeast, southern, northwest and midwest 
U.S.
Expert Raters
In a final step, we evaluated hypothesized values of 5 T-score points (5T) and 9T (derived 
from distribution and anchored approaches) for the MCID and RCID through clinical 
provider ratings of case protocols illustrating change over the course of rehabilitation. From 
the larger sample of participants, we randomly selected 9 who had participated in intensive 
rehabilitation services and changed 5T on the MPAI-4 over the course of treatment. Three 
cases were selected at each of 3 levels of disability on the MPAI-4 admission assessment: (1) 
mild disability (MPAI-4 admission T-score < 40), (2) moderate disability (MPAI-4 
admission T-score = 40–60), and (3) severe disability (MPAI-4 admission T-score > 60). We 
selected an additional 9 cases at each of these 3 initial disability levels who had participated 
in intensive rehabilitation and changed 9T over the course of treatment. Graphic displays 
illustrating change on each item over the course of treatment were made accessible to 
clinical raters over the internet. Cases were selected that showed overall positive change of 
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either 5T or 9T and not all change on individual items was in a positive direction. The rating 
clinicians were not informed about the participant’s initial disability level or that the 
protocols represented a magnitude of 5T or 9T.
Thirty clinical providers were asked to rate functional change for each of these cases on a 7-
point Clinician Rating of Global Clinical Improvement (CRGCI) scale. Clinicians were 
required to have at least 1 year experience using the MPAI-4 in a clinical setting and were 
recruited through the Pennsylvania Association for Rehabilitation Facilities and Rehab 
Without Walls. These providers included 8 speech/language pathologists, 6 clinical 
managers or directors, 5 physical therapists, 5 occupational therapists, 4 neuropsychologists, 
a psychologist, and a behavioral counselor. Raters had an average of 11.97 years (SD = 8.93) 
experience in ABI rehabilitation and 4.90 years (SD = 3.06) using the MPAI-4 and worked 
in facilities in 10 states in the eastern, western, southern, and midwestern U.S.
Measures
The MPAI-412 consists of 30 items selected to assess commonly-occurring limitations after 
BI. It is divided into three subscales: Ability Index, Adjustment Index, and Participation 
Index. Prior studies have demonstrated satisfactory internal consistency, construct 
validity3,13,14 as well as concurrent15 and predictive validity16–18 for the full measure and its 
indices. The MPAI-4 has been found to be responsive the effects of rehabilitation 
interventions.15,19,20
The Supervision Rating Scale (SRS) is a single item measure of need for supervision in the 
participant’s living situation (or conversely, of independent living) that describes 13 levels 
ranging from 24-hour supervision with physical restraints to completely independent living 
with no supervision.21 Each level marks a significant change from the adjoining levels in 
personal independence and burden of care. These 13 levels can be collapsed into 5 broader 
levels of required supervision: (1) independent, (2) overnight supervision, (3) part-time 
supervision, (4) full-time indirect supervision, and (5) full-time direct supervision.
A Clinician Rating of Global Improvement Scale (CRGCI) Scale was constructed which 
asked raters to rate each case by answering two questions: (1) “If rehabilitation began within 
the first year after brain injury, how do you rate this individual’s functional status at 
discharge compared to status on admission”; and (2) “If rehabilitation began one year or 
more after brain injury, how do you rate this individual’s status at discharge compared to 
status on admission.” For each question, ratings were made on a 7 point scale: (1) much 
better, (2) moderately better, (3) a little better, (4) no change, (5) a little worse, (6) 
moderately worse, and (7) much worse.
Procedures
We identified and evaluated the MCID for the MPAI-4 total score using both distribution-
based and anchored methods. Distribution-based methods included computation of standard 
deviation and standard error of measurement (SEM) and recommended functions of SEM. 
For example, ½ SD, 1 SEM, or 2 (or more precisely 1.96) SEM have been recommended as 
measures of MCID.10,22 These values, as well as 2.77SEM (equivalent to the Reliable 
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Change Index; RCI10), were computed both for the entire sample and for only those subjects 
who showed zero or positive change on the MPAI-4. Rasch-derived T-scores were used in all 
analyses. Procedures used in Rasch analyses and T-score development are described fully in 
the prior study.5
We examined the degree of change in the MPAI-4 Total score anchored to a change of one 
level on the standard 13-level SRS and to a change of one level on the 5-level SRS. 
Following identification of potential values for the MCID and RCID using these 
distribution-based and anchored methods, we tested these values by comparing the 
percentage of individuals who met or exceeded these levels after receiving intensive 
residential or community-based/outpatient rehabilitation services compared to individuals 
receiving supported living services. In a prior study,5 the intensive rehabilitation groups 
showed significant improvement of about 1 SD on the MPAI-4 over the course of treatment, 
whereas those in supported living services showed stable functioning from admission to 
follow-up assessment. We also compared differences on the SRS for groups that met criteria 
for our hypothesized MCID and RCID values to further test these hypotheses. As described 
previously, we ultimately evaluated hypothesized MCID and RCID values through therapist 
ratings on a CRCGI scale.
Results
Distribution-based indicators
Because T-scores were used in these analyses, the standard deviation for the full sample was 
10 by definition. We computed the SEM and recommended functions of the SEM (Table 1) 
using the Person Reliability of .89 obtained from the previous Rasch analysis of this data set 
as the reliability indicator.5 This value is very similar to the value of .91 obtained in prior 
analyses with large data sets.3–4 Values for these indicators were very similar for both the 
total sample and for the subset that showed zero or greater change on the MPAI-4 from first 
to second assessment.
SRS Anchoring
To further triangulate on the appropriate value for the MCID, we identified the optimal 
change score on the MPAI-4 through ROC analysis that differentiated those who did not 
change from first to second assessment from those who changed 1 unit on the standard 13-
level SRS. To be conservative in this evaluation, we included individuals who changed 1 unit 
but no more (n=284) versus those who showed zero change (n = 950) on the 13-level SRS. 
Optimal change was defined as the best balance between sensitivity and specificity, i.e., 
most equivalent correct identification of both groups. We conducted these analyses both for 
the full sample and the subsample that showed zero to positive change on the MPAI-4, that 
is, those with negative change on the MPAI-4 were not included. We performed similar 
analyses to determine the optimal cutpoint to differentiate those who advanced 1 unit on the 
5-level SRS (n = 724) from those who showed zero change (n = 1166). Results are 
summarized in Table 2.
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The modest % correct classification reported in Table 2 probably represents multiple factors, 
including the restricted range of scores in the selected sample; divergence in the constructs 
represented by the two instruments, i.e., a broad range of functional abilities and activities 
for the MPAI-4 compared to current level of supervision for the SRS; and the relative 
coarseness of the ordinal metric represented by the SRS. With this in mind, we considered 
the results of this analysis and proceeded with additional anchored evaluations.
MCID evaluation between treatment conditions
Based on these distribution-based and anchored estimates of the MCID, we hypothesized 
that the truly minimal clinically important difference may be about ½ SD or 5T. The SEM of 
4.07 was just below this value. We were more comfortable setting the MCID at the ½ SD 
value instead of 1 SEM since, as the minimally detectable difference, 1 SEM leaves little 
room for error resulting from varying reliability in implementation across settings. 
Furthermore, a ½ SD value has been endorsed as a reasonable estimate of the MCID for 
most measures.9 Anchored evaluation with the SRS suggested a higher value between 7.5 
and 8.5. The 1.96 SEM was also in this same range, i.e., about 8. We hypothesized that this 
level of change might indicate a more robust clinically important difference (RCID). We 
reasoned that the value of the RCID should be at least 1 SEM greater than the MCID; 
therefore, we chose 9 T-score points (9T) for the hypothesized RCID. We then tested these 
two possible values for the MCID and RCID by examining how well they differentiated 
between two groups in our sample: (1) those who demonstrated significant change as a 
group from admission to discharge from intensive rehabilitation services, and (2) those who, 
as a group, showed stable performance as a result of involvement in supported living 
services. Both values differentiated between groups with the 5T value providing clearest 
differentiation (Table 3).
MCID and RCID compared to change on SRS
To further evaluate the values of 5T for the MCID and 9T for the RCID, we divided the 
sample with available SRS scores into 3 groups: Group 1 included those who did not achieve 
a MCID on the MPAI-4 (n=719), Group 2, those who achieved a MCID but not a RCID 
(n=495), and Group 3, those who achieved a RCID (n=1512). Change on the 13-level SRS 
was then compared among these 3 groups using the Kruskal-Wallis nonparametric test 
which indicated a significant difference among the groups (Χ2=507.625, p< .001). Further 
contrasts between groups using the Wilcoxon test indicated that Group 2 showed greater 
change on the SRS than Group 1 (Z=−7.543, p<.001) and that Group 3 changed more on the 
SRS than Group 2 (Z=−11.724, p< .001).
MCID evaluation compared to clinician ratings of Global Clinical Improvement
We further evaluated the 5T and 9T benchmarks through therapist ratings on a CRGCI scale. 
Table 4 shows percentages for each rating by change level and time since injury. Ratings 
tended to be more favorable when the case was considered more than 1 year post-injury than 
less than 1 year post-injury both for a 5T change (χ2=9.81, df=4, p<.05) and for a 9T change 
(χ2 =16.20, df=3, p<.001). Ratings also were more favorable for those making a 9T change 
compared to a 5T change both when the case was considered less than 1 year post-injury 
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(χ2=114.75, df=4, p<.001) and when the case was considered greater than 1 year post-injury 
(χ2=119.14, df=4, p < .001). For these tests, cells with very small numbers were combined.
As can be seen in Table 4, virtually all raters (99%) indicated that those making a 9T change 
were at least “a little better” regardless of time since injury. For cases considered less than 1 
year post-injury, 87% of those making a 5T change were rated as at least “a little better” and, 
for those considered more than 1 year post-injury, 81% making a 5T change were rated as at 
least “a little better."
Discussion
We systematically worked through a series of distribution-based and anchored procedures to 
triangulate on the value of the MCID for the MPAI-4. Distribution-based analyses identified 
values of 1 SEM, 1.96 SEM and ½ SD that have been recommended in literature previously 
cited as viable candidates for the MCID. The initial anchored ROC analysis with reference 
to the SRS suggested a value close to 1.96SEM (i.e., ~8). However, additional anchored 
analyses using hypothesized values of 5T and 9T indicated that both these values 
significantly differentiated a group that benefited from intensive rehabilitation compared to a 
group that maintained function in supported living services. These hypothesized MCID and 
RCID values also differentiated on the SRS among groups that (1) did not achieve a MCID, 
(2) achieved a MCID but not a RCID, and (3) achieved a RCID on the MPAI-4. It may be 
that our initial anchored analysis of SRS data using ROC resulted in a slightly inflated value 
because, in fact, progress from one level to the next on the SRS indicates substantial, 
moderate change. Ultimately we evaluated our hypothesized values for the MCID and RCID 
through MPAI-4 change protocol review by experienced ABI rehabilitation providers. This 
expert panel nearly unanimously (99%) agreed that a change of 9T represents positive 
change with a substantial majority (81–87%) agreeing that a 5T represents at least a minimal 
positive change.
Our aims in this study were to identify a value that indicated the smallest change on the 
measure that is reliably associated with a meaningful clinical change, i.e., the MCID, and a 
value that indicates moderate, more robust change, i.e., the RCID. Consistent with these 
labels, a larger percentage of the experts indicated that the RCID value of 9T represented a 
change that was “moderately better” or “much better” than a change of 5T which was more 
frequently endorsed as indicating that the participant was a “little better.” (See Table 4)
In clinical practice or program evaluation, we recommend that these labels be applied at face 
value, that is, a MCID (i.e., 5T positive change) should be considered to represent a small 
but meaningful change in the rehabilitation participant’s functional status and a RCID (i.e., 
9T positive change) should be considered to represent moderate, more robust improvement. 
These values should be applied to the total score for the MPAI-4. Inspection of index (i.e., 
subscale) scores may subsequently be informative to appreciate the extent to which the 
change involved improvements in abilities, adjustment, and/or participation. Rasch analysis 
yields a metric (logit) that has equal intervals between levels. These logit scores provide an 
interval equivalent measure unlike ordinal raw scores in which small changes at the ends of 
the continuum may represent larger functional gains compared to similar raw score changes 
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in the middle of the continuum. To provide a more familiar metric, we converted the logit 
scores to T-scores. By using logit-based T-scores in our analyses, we were able to equate 
changes across the continuum of disability. For this reason, the MCID and RCID 
recommended here would be appropriately applied regardless of the participant’s initial level 
of disability.
The MPAI-4 was originally developed using mixed samples of individuals with ABI. As 
such, the MPAI-4 is a functional, not a medical diagnostic, measure and consequently we 
believe that the measure and recommended MCID and RCID can be applied to individuals 
with ABI regardless of the participant’s specific brain diagnosis. Furthermore, individuals in 
this sample were admitted to the rehabilitation or supported living programs based on 
functional evaluations and potential to benefit from participation in the specific program. 
Because selection for treatment was based on functional, not medical, evaluation, 
participants in a program are very likely as homogenous (or conversely, heterogenous) 
across medical diagnostic categories as within category. For example, in a prior study, we 
examined for potential differences between the two largest populations of ABI, stroke and 
TBI.4 Differences were found on some items between these two groups that reflected 
expected differences between more lateralized and more diffuse/frontal brain injury. 
However, any two participants in either diagnostic group will also differ in their item profiles 
depending on the specific brain regions affected by ABI, premorbid characteristics and other 
factors that create individual patterns of functional impairment. Most likely because item 
profile variability within medical diagnostic group is as great as between groups, on analysis 
of the overall measure, the test characteristic curves for the stroke and TBI groups were 
virtually identical. These considerations (i.e., medical diagnostic groups perform similarly 
on the overall measure; the MCID and RCID were based on the overall measure; and the 
original design was as a functional measure for use with mixed ABI rehabilitation 
participants) support the use of the MPAI-4 for functional evaluations and the assessment of 
change using the MCID and RCID recommended here regardless of the participant’s 
medical diagnosis. Given the large and geographically diverse nature of the sample, 
facilities, and settings, we believe that these findings would be applied appropriately in post-
inpatient brain injury rehabilitation and supported living programs. However, these values 
may differ in other settings, e.g., inpatient rehabilitation, or a different measure may be more 
appropriate for the assessment of change.
Both values for the MCID and RCID are lower than the value of the RCI of about 11. Turner 
and colleagues10 have described the limitations of and warned against using distribution-
based methods alone to determine the MCID, such as computation of the RCI. The RCI is an 
indicator of the degree of change that is statistically very unlikely to occur by chance. 
However, the RCI may not be sensitive to smaller changes that are meaningful to providers 
and participants. Our systematic analyses using multiple methods to determine the MCID 
suggest that, in the context of post-inpatient ABI rehabilitation, the RCI for the MPAI-4 
represents a conservative indicator of clinically meaningful change which may result in 
under-identification of cases that have benefited from rehabilitation as well as underestimate 
the potency of rehabilitation interventions. The MCID, in contrast, represents a degree of 
change that is likely to be clinically meaningful but does not control for measurement error 
as rigorously as the RCI. Which then represents the “true” measure of change? We suggest 
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that this would depend on the purpose of the evaluation. For example, in testing a new 
rehabilitation procedure, a researcher may elect to use the RCI of a relevant measure to 
determine whether the treatment group obtains a superior outcome compared to the control 
condition with a high degree of statistical certainty. However, in this same context, the 
researcher may also appropriately report the percent of participants achieving an MCID to 
provide clinicians with an indication of how likely it is that a given participant will obtain 
meaningful benefit from the procedure.
Limitations
While we used multiple methods to triangulate on the MCID and RCID for the MPAI-4, we 
did not include evaluation with reference to patient-reported outcomes (PRO). In this 
retrospective study, we were not able to determine a practical way to obtain the opinions of 
individuals participating in ABI rehabilitation programs about the degree of benefit that they 
felt they received from these services. The protocol reviews that we asked of therapists 
seemed too technical to be completed in a valid fashion by lay participants. The validity of 
PRO from individuals with ABI may also be questioned since these individuals may have 
difficulty assessing their status or progress because of cognitive impairments resulting from 
ABI. Nonetheless, our study would have benefited from obtaining the perspectives of 
individuals with ABI who had participated in post-inpatient rehabilitation services regarding 
the degree of change recorded on the MPAI-4 that is associated with their perception of a 
meaningful change in their functional status.
Conclusions
With reference to a large, national sample of individuals participating in post-inpatient brain 
injury rehabilitation services, we were able to triangulate on values for minimal (MCID) and 
moderate (RCID) change on the MPAI-4 through systematic application of distribution-
based and anchored methods. Results of these analyses recommend a 5T change in total 
score on the MPAI-4 as the MCID and a 9T change as the RCID. Future research may 
profitably assess the degree to which these values also represent meaningful change from the 
perspectives of participants or their significant others. These values may be used in future 
controlled or observational trials to evaluate the efficacy and effectiveness of post-inpatient 
brain rehabilitation procedures as well as to identify responders in such trials. The 
identification of responders, i.e., participants who obtain a positive change of at least a 
MCID, will be important in future rehabilitation treatment studies to characterize those who 
benefit from a specific intervention. This is particularly relevant in treatment studies 
conducted from an individualized medicine perspective in which an intervention may not 
show a significant effect when applied to a heterogeneous sample of participants who, for 
example, share a medical diagnosis, but may be effective for a subgroup within the sample 
who share specific functional, demographic, genomic, or other identifiable characteristics.
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Table 1
Distribution-based MCID indicators
Standard
Deviation
(SD)
½ SD SEM 1.96 SEM 2.77 SEM
(Reliable
Change Index)
Total Sample
(n=3087) 10.0 5.0 4.07 7.98 11.27
Sample with no
or positive
change (n=2864) 9.9 4.85 4.03 7.91 11.17
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Table 2
ROC analysis anchored to Standard (13-level) and 5-level SRS.
Optimal
Cutpoint
No change:
% correct
identification (n)
1 unit change:
% correct
identification (n)
Standard SRS
(full sample) 7.5
55%
(284)
61%
(950)
Standard SRS
(sample with zero/positive
change on MPAI-4) 8.5
54%
(268)
62%
(858)
5-level SRS
(full sample) 8.5
64%
(724)
62%
(1166)
5-level SRS
(sample with zero/positive
change on MPAI-4) 8.5
66%
(703)
59%
(1061)
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Table 3
Comparison of 5T (MCID) and 9T (RCID) benchmarks in intensive rehabilitation vs. supportive living 
participants
Intensive Rehabilitation Supported Living
≥ 5 T score change
Χ2 = 169.74, p < .001
72% 12%
≥ 9 T score change
Χ2 = 97.60, p < .001
54% 4%
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Table 4
Change ratings for hypothesized 5T and 9T change by time since injury
Rating
5T Change 9T Change
<1 Yr
Post-injury
>1 Yr
Post-injury
<1 Yr
Post-injury
>1 Yr
Post-injury
Much better 7% 8% 22% 37%
Moderately better 16% 23% 46% 36%
A little better 63% 50% 31% 26%
No change 7% 9% 1% 1%
A little worse 6% 8% 0% 1%
Moderately worse 1% 1% 0% 0%
Much worse 0% 0% 0% 0%
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